Insider Transactions in Q4 2022 at Sonnet Bio Therapeutics Holdings, Inc. (SONN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Albert D. Dyrness Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+10.88%
|
-
|
|
Dec 14
2022
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+18.46%
|
-
|
|
Dec 14
2022
|
Lori Mc Neill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+50.0%
|
-
|
|
Dec 14
2022
|
Nailesh Bhatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+10.76%
|
-
|
|
Dec 14
2022
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,551
+5.44%
|
-
|
|
Dec 14
2022
|
John Harry Cross Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,519
+8.81%
|
-
|
|
Dec 14
2022
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
74,205
+9.02%
|
-
|
|
Dec 14
2022
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,627
+9.39%
|
-
|
|
Dec 14
2022
|
Raghu Rao Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,770
+12.6%
|
-
|
|
Dec 09
2022
|
Donald J. Griffith Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,214
+22.94%
|
-
|